Please assess the completion status of the following clinical trial:

Trial Title: Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years and older~* Previous diagnosis of Barrett's esophagus, confirmed by pathology.~Exclusion Criteria:~* Patients diagnosed with any level of dysplasia on previous esophageal biopsies.~* Patients who had esophageal therapy with Halo radiofrequency ablation in the past, or esophagectomy.~* History of allergy to Acetic Acid~* History of esophageal dysplasia or cancer~* Esophageal ulcerations~* Esophageal Candida~* Esophageal Varices~* Patients with active esophagitis~* Patients who cannot provide a valid consent~* Patients who are currently pregnant

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Chromoendoscopy using Acetic Acid 2.5% (Type: EXPERIMENTAL): Patient will have endoscopic examination of esophagus. Esophageal mucosa sprayed with 5cc solution of Acetic Acid 2.5% one time only. Esophageal mucosa examined again. Biopsies are obtained. Abnormal areas identified by Acetic Acid 2.5% will be submitted on separate containers for pathology review. If no abnormalities seen, random biopsies taken as per standard recommendations for Barrett's esophagus. Samples submitted for pathology review.
- Standard random esophageal biopsies (Type: ACTIVE_COMPARATOR): Patient will have endoscopic examination of the esophagus. Esophageal mucosa will not be sprayed with Acetic Acid 2.5%. Random biopsies taken as per standard recommendations for Barrett's esophagus. Samples submitted for pathology review.

Based on this trial design, predict the completion outcome and termination type (if applicable).